These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12507543)

  • 1. Thymidine phosphorylase and dihydropyrimidine dehydrogenase in renal cell carcinoma: relationship between histological parameters and chemosensitivity to 5-fluorouracil.
    Hirano Y; Takayama T; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Eur Urol; 2003 Jan; 43(1):45-51; discussion 51-2. PubMed ID: 12507543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in transitional cell cancer.
    Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):29-35. PubMed ID: 12497203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidine phosphorylase activity in renal cell carcinoma: relationship between histological parameters and chemosensitivity to fluorouracil-related drugs.
    Hirano Y; Takayama T; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Urol Res; 2002 May; 30(2):112-5. PubMed ID: 12086015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of dihydropyrimidine dehydrogenase activity in renal cell carcinoma.
    Mizutani Y; Wada H; Yoshida O; Fukushima M; Nakanishi H; Nakao M; Miki T
    Eur J Cancer; 2003 Mar; 39(4):541-7. PubMed ID: 12751387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidine phosphorylase activity in transitional cell cancer: relation to histological parameters and chemosensitivity to fluorouracil-related drugs.
    Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Anticancer Res; 2000; 20(6B):4315-8. PubMed ID: 11205264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine phosphorylase and dihydropyrimidine dehydrogenase activity in colorectal carcinoma and patients prognosis.
    Ikeguchi M; Makino M; Kaibara N
    Langenbecks Arch Surg; 2002 Oct; 387(5-6):240-5. PubMed ID: 12410361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting 5-FU sensitivity using human colorectal cancer specimens: comparison of tumor dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activities with in vitro chemosensitivity to 5-FU.
    Isshi K; Sakuyama T; Gen T; Nakamura Y; Kuroda T; Katuyama T; Maekawa Y
    Int J Clin Oncol; 2002 Dec; 7(6):335-42. PubMed ID: 12494248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of thymidylate synthase activity in renal cell carcinoma.
    Mizutani Y; Wada H; Yoshida O; Fukushima M; Nonomura M; Nakao M; Miki T
    Clin Cancer Res; 2003 Apr; 9(4):1453-60. PubMed ID: 12684419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
    Terashima M; Fujiwara H; Takagane A; Abe K; Irinoda T; Nakaya T; Yonezawa H; Oyama K; Saito K; Kanzaki N; Ohtani S; Nemoto T; Hoshino Y; Kogure M; Gotoh M
    Gastric Cancer; 2003; 6 Suppl 1():71-81. PubMed ID: 12775024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase in renal cell carcinoma.
    Morita T; Matsuzaki A; Tokue A
    Oncology; 2003; 65(2):125-31. PubMed ID: 12931018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The correlation between thymidine phosphorylase activity of renal cancer cells and the chemosensitivity to 5-FU and 5'-DFUR].
    Hirano Y; Takayama T; Ushiyama T; Suzuki K; Fujita K
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1779-81. PubMed ID: 9757207
    [No Abstract]   [Full Text] [Related]  

  • 12. The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer.
    Mizutani Y; Wada H; Fukushima M; Yoshida O; Ukimura O; Kawauchi A; Miki T
    Eur J Cancer; 2001 Mar; 37(5):569-75. PubMed ID: 11290431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.
    Salonga D; Danenberg KD; Johnson M; Metzger R; Groshen S; Tsao-Wei DD; Lenz HJ; Leichman CG; Leichman L; Diasio RB; Danenberg PV
    Clin Cancer Res; 2000 Apr; 6(4):1322-7. PubMed ID: 10778957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil.
    Ishikawa Y; Kubota T; Otani Y; Watanabe M; Teramoto T; Kumai K; Takechi T; Okabe H; Fukushima M; Kitajima M
    Jpn J Cancer Res; 2000 Jan; 91(1):105-12. PubMed ID: 10744051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-fluorouracil sensitivity and dihydropyrimidine dehydrogenase activity in advanced gastric cancer.
    Inada T; Ogata Y; Kubota T; Tomikawa M; Yamamoto S; Andoh J; Ozawa I; Hishinuma S; Shimizu H; Kotake K
    Anticancer Res; 2000; 20(4):2457-62. PubMed ID: 10953310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthase and dihydropyrimidine dehydrogenase activities in non-small cell lung cancer tissues: relationship with in vitro sensitivity to 5-fluorouracil.
    Higashiyama M; Kodama K; Yokouchi H; Takami K; Fukushima M; Minamigawa K; Takano T; Kobayashi H
    Lung Cancer; 2001 Dec; 34(3):407-16. PubMed ID: 11714538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2'-deoxyuridine.
    Ma T; Zhu ZG; Ji YB; Zhang Y; Yu YY; Liu BY; Yin HR; Lin YZ
    World J Gastroenterol; 2004 Jan; 10(2):172-6. PubMed ID: 14716816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydropyrimidine dehydrogenase activity of cancerous and non-cancerous tissues in liver and large intestine.
    Ikeguchi M; Hirooka Y; Makino M; Kaibara N
    Oncol Rep; 2001; 8(3):621-5. PubMed ID: 11295091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil.
    Mizutani Y; Nakanishi H; Yoshida O; Fukushima M; Bonavida B; Miki T
    Eur J Cancer; 2002 Jan; 38(1):167-76. PubMed ID: 11750847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.